TMS denied as non-formulary by Aetna?

Aetna's specific coverage criteria for tms are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why Aetna Denies TMS as Non-Formulary — and How to Appeal

Although "formulary" language typically applies to prescription drugs, Aetna and other insurers sometimes apply analogous coverage-tier logic to procedures and devices, including transcranial magnetic stimulation (TMS). A non-formulary or non-covered-benefit denial for TMS means Aetna has classified TMS as either outside your specific plan's covered benefits or as a service requiring a higher tier of clinical justification than was provided. This classification can also appear when TMS is covered for some diagnoses but not the one on your claim.

## Why This Denial Is Appealable

Non-formulary or non-covered-benefit denials for TMS are worth challenging because: (a) your plan documents (Summary Plan Description or Evidence of Coverage) may include TMS as a covered benefit even if the claim was denied, (b) federal mental-health parity law (the Mental Health Parity and Addiction Equity Act — MHPAEA) prohibits applying more restrictive benefit limitations to mental-health services than to analogous medical/surgical services, and (c) if TMS is FDA-cleared for your diagnosis, the experimental exclusion basis is weakened. Parity violations are a powerful appellate argument.

## Federal Appeal Framework

• Internal appeal: File within 180 days of denial. Request the specific plan provision Aetna relied upon and a copy of the non-quantitative treatment limitation (NQTL) analysis if the denial involves a behavioral-health service.
• MHPAEA parity complaint: Simultaneously file a parity complaint with your state insurance commissioner or, for self-insured ERISA plans, with the U.S. Department of Labor Employee Benefits Security Administration.
• External review (ACA §2719 / ERISA §503): After exhausting internal review, request independent external review within approximately four months of the final adverse determination.
• Expedited review: Available when standard timelines threaten health.

## Documentation to Gather

1. Your plan documents: Summary Plan Description and Evidence of Coverage — identify the TMS benefit language and any exclusion language cited in the denial letter. 2. Diagnosis and severity records: Treating clinician records confirming diagnosis, severity, and why TMS is the appropriate treatment. 3. FDA clearance for your indication: Printout from fda.gov confirming TMS device clearance for your specific diagnosis — undercuts any experimental-exclusion basis. 4. Parity comparator analysis: Ask your clinician or an attorney to identify a comparable medical/surgical service that Aetna covers (e.g., a neurostimulation or neuromodulation procedure for a physical condition) and document that TMS for your diagnosis is being treated more restrictively — this is the substance of a parity argument. 5. Prescriber letter: Addressing both medical necessity and the parity basis for coverage.

## Criteria-Mapping Structure

Pull the denial letter and the relevant section of Aetna's Clinical Policy Bulletin from Aetna.com. Map each stated basis for non-coverage to a specific rebuttal: plan-document language, FDA status, or parity comparator. If the denial does not cite a specific plan exclusion, note that ambiguity in benefit language is typically construed in the member's favor under ERISA plan-interpretation principles.